EPCORE FL-1: Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Sponsor
AbbVie (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05409066
Collaborator
Genmab (Industry)
642
268
3
87.7
2.4
0

Study Details

Study Description

Brief Summary

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with relapsed or refractory (R/R) FL. Adverse events and change in disease condition will be assessed.

Epcoritamab is an investigational drug being developed for the treatment of FL. Study doctors put the participants in 1 of 3 groups, called treatment arms. Each group receives a different treatment. Around 642 adult participants with R/R FL will be enrolled in approximately 300 sites across the world.

Participants will receive R2 (intravenous infusion of rituximab up to 5 cycles and oral capsules of lenalidomide for up to 12 cycles) alone or in combination with subcutaneous injections of epcoritamab for up to 12 cycles (each cycle is 28 days).

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
642 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)
Anticipated Study Start Date :
Sep 7, 2022
Anticipated Primary Completion Date :
Dec 27, 2029
Anticipated Study Completion Date :
Dec 27, 2029

Arms and Interventions

Arm Intervention/Treatment
Experimental: Epcoritamab Dose A in Combination With R2

Participants will receive epcoritamab Dose A in combination with lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days).

Drug: Epcoritamab
Subcutaneous Injection
Other Names:
  • GEN3013
  • Drug: Rituximab
    Intravenous Infusion

    Drug: Lenalidomide
    Oral Capsules

    Experimental: Epcoritamab Dose B in Combination With R2

    Participants will receive epcoritamab Dose B in combination with lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days).

    Drug: Epcoritamab
    Subcutaneous Injection
    Other Names:
  • GEN3013
  • Drug: Rituximab
    Intravenous Infusion

    Drug: Lenalidomide
    Oral Capsules

    Active Comparator: Lenalidomide and Rituximab (R2)

    Participants will receive lenalidomide and rituximab (R2) for 12 cycles (each cycle is 28 days).

    Drug: Rituximab
    Intravenous Infusion

    Drug: Lenalidomide
    Oral Capsules

    Outcome Measures

    Primary Outcome Measures

    1. Progression-Free Survival (PFS) [Up to approximately 5 years]

      PFS is defined as duration from the date of randomization to the date of disease progression determined by Lugano criteria by independent review committee (IRC) or death (whichever occurs first).

    Secondary Outcome Measures

    1. Percentage of Participants Achieving Complete Response (CR) [Up to approximately 5 years]

      Percentage of participants who achieve a CR determined per Lugano criteria, as assessed by the IRC prior to the initiation of subsequent anti-lymphoma therapy.

    2. Percentage of Participants Achieving Best Overall Response (BOR) [Up to approximately 5 years]

      Percentage of participants who achieve the BOR of complete response (CR) or partial response (PR) determined per Lugano criteria, as assessed by the IRC prior to the initiation of subsequent anti-lymphoma therapy.

    3. Overall Survival (OS) [Up to approximately 8 years from randomization]

      Overall survival is defined as the duration from the date of randomization to the date of the participant's death.

    4. Percentage of Participants Achieving Minimal Residual Disease (MRD) Negativity [Up to approximately 5 years]

      MRD negativity rate is defined as the percentage of participants who achieve MRD negative status prior to the initiation of subsequent anti-lymphoma therapy.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Eastern Cooperative Oncology Group (ECOG) performance status score 0 to 2.

    • Participant has:

    • Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan demonstrating positive lesion compatible with computed tomography (CT) or magnetic resonance image (MRI)-defined anatomical tumor sites AND

    • = 1 measurable nodal lesion (long axis >= 1.5 cm and short axis > 1.0 cm) or >= 1 measurable extra-nodal lesion (long axis >= 1.0 cm) on CT scan or MRI.

    • Histologically confirmed Grade 1 to 3a follicular lymphoma (FL) according to the World Health Organization (WHO) 2016 classification with no evidence of histologic transformation to an aggressive lymphoma at most recent representative tumor biopsy and CD20+ on a representative tumor biopsy based on the pathology report.

    • Relapsed or refractory (R/R) disease to at least one prior systemic regimen that contained an anti-CD20 monoclonal antibody (mAb) in combination with (an)other anti-lymphoma agent(s).

    • Eligible to receive R2 per investigator determination.

    Exclusion Criteria:
    • Documented refractoriness to lenalidomide.

    • Have lenalidomide exposure within 12 months prior to randomization.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sutter Health Alta Bates Summit Medical Center /ID# 229428 Berkeley California United States 94705-2067
    2 Providence St. Joseph Medical center /ID# 228835 Burbank California United States 91505
    3 Orange Coast Medical Center /ID# 229634 Fountain Valley California United States 92708-6728
    4 Marin Cancer Care /ID# 227207 Greenbrae California United States 94904
    5 Saddleback Memorial Medical Center /ID# 229633 Laguna Hills California United States 92653-3689
    6 Long Beach Memorial Medical Ct /ID# 228997 Long Beach California United States 90806-1701
    7 University of Southern California /ID# 227195 Los Angeles California United States 90033
    8 Kaiser Permanente, Waterpark III Institute for Health Research /ID# 228619 Aurora Colorado United States 80014
    9 Christiana Care Health Service /ID# 228268 Newark Delaware United States 19713
    10 Holy Cross Hospital /ID# 228541 Fort Lauderdale Florida United States 33308
    11 Baptist MD Anderson Cancer Center - Jacksonville /ID# 227270 Jacksonville Florida United States 32207-8432
    12 Emory University /ID# 227299 Atlanta Georgia United States 30322-1013
    13 Augusta University Georgia Cancer Center /ID# 227313 Augusta Georgia United States 30912-0003
    14 Northwestern University /ID# 227248 Chicago Illinois United States 60611-2927
    15 Southern IL Univ School of Med /ID# 229000 Springfield Illinois United States 62702
    16 Goshen Center for Cancer Care /ID# 227189 Goshen Indiana United States 46526
    17 Univ Maryland School Medicine /ID# 227191 Baltimore Maryland United States 21201-1544
    18 Massachusetts General Hospital /ID# 245233 Boston Massachusetts United States 02114
    19 UMass Chan Medical School /ID# 227323 Worcester Massachusetts United States 01655
    20 Henry Ford Health System /ID# 227250 Detroit Michigan United States 48202
    21 Mmcorc /Id# 227177 Saint Louis Park Minnesota United States 55416
    22 Alliance for Multispecialty Research (AMR) - Kansas City /ID# 231075 Kansas City Missouri United States 64114-4859
    23 Morristown Medical Center /ID# 231427 Morristown New Jersey United States 07960-6136
    24 Roswell Park Comprehensive Cancer Center /ID# 239128 Buffalo New York United States 14263
    25 NYU Langone - Laura and Isaac Perlmutter Cancer Center /ID# 227322 New York New York United States 10016-4744
    26 Icahn School of Medicine at Mount Sinai /ID# 227181 New York New York United States 10029-6504
    27 Memorial Sloan Kettering Cancer Center-Koch Center /ID# 227193 New York New York United States 10065-6007
    28 Novant Health Presbyterian Medical Center /ID# 228182 Charlotte North Carolina United States 28204
    29 East Carolina University Brody School of Medicine /ID# 227192 Greenville North Carolina United States 27834
    30 Novant Health Forsyth Medical Center /ID# 228340 Winston-Salem North Carolina United States 27103
    31 Gabrail Cancer Center Research /ID# 227204 Canton Ohio United States 44718
    32 The Christ Hospital /ID# 229335 Cincinnati Ohio United States 45219
    33 Fox Chase Cancer Center /ID# 231484 Philadelphia Pennsylvania United States 19111
    34 Lankenau Medical Center /ID# 228921 Wynnewood Pennsylvania United States 19096
    35 Medical University of South Carolina /ID# 227351 Charleston South Carolina United States 29425
    36 Gibbs Cancer Center & Research /ID# 229373 Spartanburg South Carolina United States 29303-3040
    37 Thompson Cancer Survival Ctr /ID# 228295 Knoxville Tennessee United States 37916
    38 Baylor Scott & White Medical Center- Temple /ID# 227185 Temple Texas United States 76508-0001
    39 Virginia Commonwealth University Medical Center Main Hospital /ID# 227211 Richmond Virginia United States 23219
    40 UW, Cancer Ctr ProHealth Care /ID# 228746 Waukesha Wisconsin United States 53188
    41 Instituto FIDES /ID# 231500 La Plata Buenos Aires Argentina 1900
    42 Hospital Universitario Austral /ID# 230865 Pilar Buenos Aires Argentina 1629
    43 Hospital Italiano de Buenos Aires /ID# 229699 Ciudad Autonoma Buenos Aires Ciuadad Autonoma De Buenos Aires Argentina 1199
    44 Fundaleu /Id# 229700 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires Argentina 1114
    45 Hospital Aleman /ID# 229698 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires Argentina 1118
    46 Cemic /Id# 229697 Ciudad Autonoma de Buenos Aire Ciuadad Autonoma De Buenos Aires Argentina 1431
    47 Hospital Privado Univesitario /ID# 229701 Cordoba Argentina 5016
    48 Clinica de Nefrologia, Urologia y Enfermedades Cardiovasculares /ID# 232124 Santa Fe Argentina 3000
    49 Royal Prince Alfred Hospital /ID# 239272 Camperdown New South Wales Australia 2050
    50 Nepean Hospital /ID# 239093 Kingswood New South Wales Australia 2747
    51 Townsville University Hospital /ID# 231124 Douglas Queensland Australia 4814
    52 Royal Hobart Hospital /ID# 228496 Hobart Tasmania Australia 7000
    53 Peninsula Private /ID# 238796 Langwarrin Victoria Australia 3910
    54 Fiona Stanley Hospital /ID# 231122 Murdoch Western Australia Australia 6150
    55 Royal Perth Hospital /ID# 230456 Perth Western Australia Australia 6000
    56 Universitaetsklinikum St. Poelten /ID# 234015 Sankt Poelten Niederoesterreich Austria 3100
    57 Landeskrankenhaus Salzburg-Universitätsklinikum der PMU (LKH) /ID# 228366 Salzburg Austria 5020
    58 Uza /Id# 228521 Edegem Antwerpen Belgium 2650
    59 Pôle Hospitalier Jolimont /ID# 228520 La Louvière Belgium 7100
    60 Groupe Sante CHC - Clinique du MontLegia /ID# 230415 Liege Belgium 4000
    61 AZ Nikolaas /ID# 228525 Sint-Niklaas Belgium 9100
    62 AZ Turnhout - Campus Sint-Elisabeth /ID# 231628 Turnhout Belgium 2300
    63 Hospital de Clinicas da Universidade Federal do Paraná /ID# 228123 Curitiba Parana Brazil 80060-900
    64 Hospital Amaral Carvalho /ID# 228129 Jaú Sao Paulo Brazil 17210-070
    65 Fundacao Antonio Prudente - AC Camargo Cancer Center /ID# 228130 São Paulo Sao Paulo Brazil 01509-900
    66 Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) /ID# 228706 Rio de Janeiro Brazil 20231-050
    67 Real e Benemérita Associação Portuguesa de Beneficência /ID# 228121 Sao Paulo Brazil 01323-001
    68 Instituto de Assistencia Medica ao Servidor Publico Estadual /ID# 230182 Sao Paulo Brazil 04039-901
    69 Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo /ID# 228127 Sao Paulo Brazil 05403-000
    70 BC Cancer - Vancouver /ID# 228850 Vancouver British Columbia Canada V5Z 1L3
    71 Saint John Regional Hospital /ID# 233548 Saint John New Brunswick Canada E2L 4L2
    72 Princess Margaret Cancer Centre /ID# 238413 Toronto Ontario Canada M5G 2M9
    73 CISSS de la Monteregie /ID# 238412 Greenfield Park Quebec Canada J4V 2H1
    74 CHUQ- Hôpital de l'Enfant-Jesus /ID# 231537 Quebec City Quebec Canada G1J 1Z4
    75 CSSS Alphonse-Desjardins, CHAU de Levis /ID# 229896 Quebec City Quebec Canada G6V 3Z1
    76 CISSSBSL -Hopital regional de Rimouski /ID# 229894 Rimouski Quebec Canada G5L 5T1
    77 Peking University Third Hospital /ID# 230885 Beijing Beijing China 100191
    78 Fujian Medical University Union Hospital /ID# 233919 Fuzhou Fujian China 350001
    79 Sun Yat-Sen University Cancer Center /ID# 231463 Guangzhou Guangdong China 510060
    80 Guangdong Provincial People's Hospital /ID# 232512 Guangzhou Guangdong China 510080
    81 Nanfang Hospital of Southern Medical University /ID# 230383 Guangzhou Guangdong China 510515
    82 The Fourth Hospital of Hebei Medical University /ID# 238657 Shijiazhuang Hebei China 050011
    83 Henan Cancer Hospital /ID# 230459 Zhengzhou Henan China 450008
    84 Hubei Cancer Hospital /ID# 232255 Wuhan Hubei China 430079
    85 Hunan Cancer Hospital /ID# 232153 Changsha Hunan China 410006
    86 Jiangsu Cancer Hospital /ID# 232470 Nanjing Jiangsu China 210009
    87 The First Affiliated Hospital of Soochow University /ID# 232511 Suzhou Jiangsu China 215006
    88 The Affiliated Hospital of Xuzhou Medical University /ID# 232513 Xuzhou Jiangsu China 221000
    89 The First Affiliated Hospital of Nanchang University /ID# 231047 Nanchang Jiangxi China 330006
    90 The First Hospital of China Medical University /ID# 232509 Shenyang Liaoning China 110001
    91 Xijing Hospital /ID# 238650 Xian Shanxi China 710032
    92 The Affiliated Cancer Hospital of Xinjiang Medical University /ID# 238893 Urumqi Xinjiang China 830000
    93 Yunnan Cancer Hospital /ID# 232062 Kunming Yunnan China 650118
    94 The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 230390 Hangzhou Zhejiang China 310006
    95 Zhejiang Cancer hospital /ID# 231389 Hangzhou Zhejiang China 310022
    96 Jiangxi Cancer Hospital /ID# 232507 Nanchang China 330029
    97 Tianjin Medical University Cancer Institute and Hospital /ID# 230876 Tianjin China 300060
    98 Fakultni Nemocnice Brno /ID# 228271 Brno Czechia 625 00
    99 Fakultni nemocnice Hradec Kralove /ID# 228269 Hradec Kralove Czechia 500 05
    100 Fakultni nemocnice Kralovske Vinohrady /ID# 228564 Praha Czechia 100 34
    101 Vseobecna fakultni nemocnice v Praze /ID# 228565 Praha Czechia 128 08
    102 Fakultni Nemocnice v Motole /ID# 228272 Praha Czechia 150 06
    103 Aarhus University Hospital /ID# 229740 Aarhus N Midtjylland Denmark 8200
    104 Sygehus Lillebælt, Vejle /ID# 227404 Vejle Syddanmark Denmark 7100
    105 Regionshospitalet Godstrup /ID# 227466 Herning Denmark 7400
    106 CHU Clermont-Ferrand /ID# 238676 Clermont Auvergne-Rhone-Alpes France 63100
    107 HCL - Hôpital Lyon Sud /ID# 231449 Pierre Benite CEDEX Auvergne-Rhone-Alpes France 69495
    108 CHU de Rennes - PONTCHAILLOU /ID# 230356 Rennes Bretagne France 35000
    109 CHU Dijon /ID# 230354 Dijon Cote-d Or France 21000
    110 CHU Limoges - Dupuytren 1 /ID# 231450 Limoges CEDEX 1 Franche-Comte France 87042
    111 CHU NIMES - Hopital Caremeau /ID# 230351 Nimes CEDEX 9 Gard France 30029
    112 CHU Bordeaux - Hopital Haut Leveque /ID# 230347 Pessac CEDEX Gironde France 33604
    113 CHRU Lille - Hopital Claude Huriez /ID# 230353 Lille Hauts-de-France France 59037
    114 CHRU Nancy - Hôpitaux de Brabois /ID# 241595 Vandœuvre-lès-Nancy Meurthe-et-Moselle France 54500
    115 CHU de Nantes, Hotel Dieu -HME /ID# 245928 Nantes Pays-de-la-Loire France 44000
    116 CHU Poitiers - La milétrie /ID# 230357 Poitiers Poitou-Charentes France 86000
    117 Centre Leon Berard /ID# 230348 Lyon CEDEX 08 Rhone France 69373
    118 Hopital Henri Mondor /ID# 230358 Creteil France 94000
    119 CHD Vendée- La Roche-sur-Yon - Les Oudairies /ID# 234095 La Roche Sur Yon France 85000
    120 AP-HP - Hopital Saint-Louis /ID# 232067 Paris France 75010
    121 Hopital Pitie Salpetriere /ID# 230360 Paris France 75013
    122 IUCT Oncopole /ID# 233486 Toulouse Cedex 9 France 31059
    123 Universitaetsklinikum Tuebingen /ID# 229663 Tubingen Baden-Wuerttemberg Germany 72076
    124 Universitaetsklinikum Giessen /ID# 234245 Gießen Hessen Germany 35392
    125 Universitaetsklinikum Leipzig /ID# 242907 Leipzig Sachsen Germany 04103
    126 Universitaetsklinikum Jena /ID# 232064 Jena Thueringen Germany 07747
    127 Sozialstiftung Bamberg /ID# 229184 Bamberg Germany 96049
    128 Helios Klinikum Berlin-Buch /ID# 229178 Berlin Germany 13125
    129 Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 229754 Dresden Germany 01307
    130 Universitaetsklinikum Essen /ID# 229180 Essen Germany 45147
    131 SRH Wald-Klinikum Gera /ID# 232117 Gera Germany 07548
    132 Universitaetsmedizin Goettingen /ID# 230411 Goettingen Germany 37075
    133 Klinikum Kassel /ID# 229185 Kassel Germany 34125
    134 Otto-von-Guericke-Universitaet /ID# 230144 Magdeburg Germany 39120
    135 Klinikum Mutterhaus der Borromäerinnen /ID# 232354 Trier Germany 54290
    136 Universitaetsklinikum Wuerzburg /ID# 229278 Wuerzburg Germany 97080
    137 General Hospital of Athens Laiko /ID# 226626 Athens Attiki Greece 11527
    138 Alexandra General Hospital /ID# 226632 Athens Attiki Greece 11528
    139 University General Hospital Attikon /ID# 226629 Athens Attiki Greece 12462
    140 General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 226633 Athens Greece 10676
    141 University General Hospital of Ioannina /ID# 226628 Ioannina Greece 45500
    142 General University Hospital of Thessaloniki AXEPA /ID# 226630 Thessaloniki Greece 54636
    143 Theageneio Anticancer Hospital /ID# 226627 Thessaloniki Greece 54639
    144 Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont /ID# 229289 Szeged Csongrad Hungary 6725
    145 Debreceni Egyetem Klinikai Kozpont /ID# 229287 Debrecen Hajdu-Bihar Hungary 4032
    146 Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz Josa Andras Okta /ID# 232203 Nyíregyháza Nyiregyhaza Hungary 4400
    147 Somogy Megyei Kaposi Mor Oktato Korhaz /ID# 246475 Kaposvár Somogy Hungary 7400
    148 Markusovszky Egyetemi Oktatokorhaz /ID# 229290 Szombathely Vas Hungary 9700
    149 Semmelweis Egyetem /ID# 229291 Budapest Hungary 1085
    150 Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 229286 Budapest Hungary 1097
    151 Orszagos Onkologiai Intezet /ID# 229292 Budapest Hungary 1122
    152 The Chaim Sheba Medical Center /ID# 228322 Ramat Gan Tel-Aviv Israel 5265601
    153 Tel Aviv Sourasky Medical Center /ID# 228529 Tel Aviv-Yafo Tel-Aviv Israel 6423906
    154 Assaf Harofeh Medical Center /ID# 228037 Be'Er Ya'Akov Israel 70300
    155 Rambam Health Care Campus /ID# 227849 Haifa Israel 3109601
    156 Hadassah /ID# 227846 Jerusalem Israel 91120
    157 Rabin Medical Center /ID# 228043 Petakh Tikva Israel 4941492
    158 Ziv Medical Center /ID# 232257 Safed Israel 13100
    159 Fondazione di Religione e di Culto Casa Sollievo della Sofferenza /ID# 228458 San Giovanni Rotondo Foggia Italy 71013
    160 Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 230402 Rome Lazio Italy 00168
    161 Ospedale San Raffaele IRCCS /ID# 228669 Milan Lombardia Italy 20132
    162 IEO -Istituto Europeo di Oncologia /ID# 227396 Milan Milano Italy 20141
    163 Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino /ID# 229820 Torino Piemonte Italy 10126
    164 Istituto di Candiolo Fondazione del Piemonte per l'Oncologia IRCCS /ID# 229602 Candiolo Torino Italy 10060
    165 Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo /ID# 227401 Alessandria Italy 15121
    166 Centro di Riferimento Oncologico /ID# 227395 Aviano Italy 33081
    167 I.R.C.C.S Istituto Tumori Giovanni Paolo II /ID# 227400 Bari Italy 70124
    168 ASST Spedali civili di Brescia /ID# 227397 Brescia Italy 25123
    169 Azienda Ospedaliera Universitaria Federico II /ID# 230403 Napoli Italy 80131
    170 Azienda Ospedaliero Universitaria Maggiore della Carita di Novara /ID# 227399 Novara Italy 28100
    171 A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 227402 Palermo Italy 90146
    172 Ospedale Santa Maria Croci /ID# 227394 Ravenna Italy 48121
    173 NHO Nagoya Medical Center /ID# 230678 Nagoya-shi Aichi Japan 460-0001
    174 Aichi Cancer Center Hospital /ID# 230134 Nagoya-shi Aichi Japan 464-8681
    175 National Cancer Center Hospital East /ID# 232423 Kashiwa-shi Chiba Japan 277-8577
    176 Kyushu University Hospital /ID# 230136 Fukuoka-shi Fukuoka Japan 812-8582
    177 Hokkaido University Hospital /ID# 231443 Sapporo-shi Hokkaido Japan 060-8648
    178 Kagoshima University Hospital /ID# 232251 Kagoshima-shi Kagoshima Japan 890-8520
    179 Kyoto University Hospital /ID# 231156 Kyoto-shi Kyoto Japan 606-8507
    180 Tohoku University Hospital /ID# 232303 Sendai-shi Miyagi Japan 9808574
    181 Okayama University Hospital /ID# 232009 Okayama-shi Okayama Japan 700-8558
    182 Kindai University Hospital /ID# 232152 Osakasayama-shi Osaka Japan 589-8511
    183 National Cancer Center Hospital /ID# 230004 Chuo-ku Tokyo Japan 104-0045
    184 Yamagata University Hospital /ID# 230005 Yamagata-shi Yamagata Japan 990-9585
    185 Seoul National University Bundang Hospital /ID# 228448 Seongnam Gyeonggido Korea, Republic of 13620
    186 Inje University Busan Paik Hospital /ID# 230293 Busan Korea, Republic of 47392
    187 Dong-A University Hospital /ID# 228638 Busan Korea, Republic of 49201
    188 Pusan National University Hospital /ID# 229798 Busan Korea, Republic of 49241
    189 Keimyung University Dongsan Medical Center /ID# 229800 Daegu Korea, Republic of 41931
    190 Jeonbuk National University Hospital /ID# 228908 Jeonju Korea, Republic of 54907
    191 Seoul National University Hospital /ID# 228446 Seoul Korea, Republic of 03080
    192 Asan Medical Center /ID# 228444 Seoul Korea, Republic of 05505
    193 Samsung Medical Center /ID# 228445 Seoul Korea, Republic of 06351
    194 The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 228447 Seoul Korea, Republic of 06591
    195 Amphia Ziekenhuis /ID# 247739 Breda Netherlands 4818 CK
    196 Middlemore Clinical Trials /ID# 228509 Papatoetoe Auckland New Zealand 2025
    197 North Shore Hospital /ID# 228508 Takapuna Auckland New Zealand 0622
    198 Palmerston North Hospital /ID# 232352 Palmerston North Manawatu-Wanganui New Zealand 4442
    199 Wellington Regional Hospital /ID# 234104 Newtown Wellington New Zealand 6021
    200 Pratia MCM Krakow /ID# 229121 Krakow Malopolskie Poland 30-510
    201 Szpitale Pomorskie Sp. z o.o /ID# 229122 Gdynia Pomorskie Poland 81-519
    202 Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej /ID# 229362 Kielce Swietokrzyskie Poland 25-734
    203 ARS-MEDICAL Sp. z o.o. /ID# 229601 Pila Wielkopolskie Poland 64-920
    204 Pratia SA /ID# 229299 Skorzewo Wielkopolskie Poland 60-185
    205 Hematology and Oncology Institute /ID# 230056 Manati Puerto Rico 00674
    206 Pan American Center for Oncology Trials, LLC /ID# 230055 Rio Piedras Puerto Rico 00935
    207 Republican Oncological Clinical Dispensary /ID# 230432 Kazan Tatarstan, Respublika Russian Federation 420029
    208 Narodny Onkologicky ustav /ID# 239510 Bratislava Slovakia 831 01
    209 Univerzitna nemocnica L. Pasteura Kosice /ID# 240175 Kosice Slovakia 040 01
    210 Univerzitna nemocnica Martin /ID# 240827 Martin Slovakia 036 01
    211 Wits Clinical Research Site /ID# 228895 Johannesburg Gauteng South Africa 2193
    212 Albert Alberts Stem Cell Transplant Centre /ID# 228896 Pretoria Gauteng South Africa 0044
    213 University of Cape Town /ID# 228900 Cape Town Western Cape South Africa 7925
    214 Haemalife Inc. Netcare Kuilsrivier Hospital /ID# 243392 Kuilsrivier Western Cape South Africa 7580
    215 Instituto Catalan de Oncologia (ICO) Badalona /ID# 228108 Badalona Barcelona Spain 08916
    216 Instituto Catalan de Oncologia (ICO) L'Hospitalet /ID# 228107 Hospitalet de Llobregat Barcelona Spain 08908
    217 Hospital Unversitario Marques de Valdecilla /ID# 228984 Santander Cantabria Spain 39008
    218 CLINICA UNIVERSIDAD DE NAVARRA-Pamplona /ID# 228116 Pamplona Navarra Spain 31008
    219 Hospital Parc de Salut del Mar /ID# 228106 Barcelona Spain 08003
    220 Hospital Santa Creu i Sant Pau /ID# 229859 Barcelona Spain 08041
    221 Hospital Universitario Reina Sofia /ID# 228122 Cordoba Spain 14004
    222 CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 229157 Madrid Spain 28027
    223 MD Anderson Madrid /ID# 229860 Madrid Spain 28033
    224 Hospital Universitario Ramon y Cajal /ID# 228113 Madrid Spain 28034
    225 Hospital Universitario Fundacion Jimenez Diaz /ID# 228110 Madrid Spain 28040
    226 Hospital Universitario 12 de Octubre /ID# 228109 Madrid Spain 28041
    227 Hospital Universitario La Paz /ID# 228111 Madrid Spain 28046
    228 Hospital Universitario de Salamanca /ID# 228117 Salamanca Spain 37711
    229 Hospital Universitario Virgen del Rocio /ID# 228118 Sevilla Spain 41013
    230 Hallands Hospital Halmstad /ID# 229868 Halmstad Hallands Lan Sweden 302 33
    231 Sunderby sjukhus /ID# 228165 Lulea Norrbottens Lan Sweden 971 80
    232 Sodra Alvsborgs sjukhus /ID# 228886 Boras Vastra Gotalands Lan Sweden 501 82
    233 Sahlgrenska University Hospital /ID# 229658 Gothenburg Vastra Gotalands Lan Sweden 413 45
    234 Linkoping University Hospital /ID# 233520 Linkoping Sweden 581 85
    235 Kantonsspital Aarau AG /ID# 229113 Aarau Aargau Switzerland 5001
    236 Kantonsspital St. Gallen /ID# 229117 St. Gallen Sankt Gallen Switzerland 9007
    237 EOC Ospedale Regionale di Bellinzona e Valli /ID# 228922 Bellinzona Ticino Switzerland 6500
    238 Universitätsspital Zürich /ID# 228920 Zürich Zuerich Switzerland 8091
    239 Kaohsiung Chang Gung Memorial Hospital /ID# 227384 Kaohsiung Taiwan 833
    240 China Medical University Hospital /ID# 227379 Taichung City Taiwan 40447
    241 Taichung Veterans General Hospital /ID# 227383 Taichung Taiwan 40705
    242 National Cheng Kung University Hospital /ID# 227381 Tainan Taiwan 704
    243 Taipei Veterans General Hosp /ID# 227380 Taipei City Taiwan 11217
    244 Ankara Universitesi Fakultesi /ID# 227790 Ankara Turkey 06620
    245 Akdeniz Universitesi Tip Fakul /ID# 227791 Antalya Turkey 07059
    246 Dicle Universitesi Tip /ID# 230087 Diyarbakir Turkey 21200
    247 Istanbul Florence Nightingale Hastanesi /ID# 229546 Istanbul Turkey 34200
    248 Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi /ID# 227855 Istanbul Turkey 34899
    249 Ege University Medical Faculty /ID# 227792 Izmir Turkey 35040
    250 Kocaeli University Med Faculty /ID# 227854 Kocaeli Turkey 41380
    251 Ondokuz mayis University Facul /ID# 227794 Samsun Turkey 55200
    252 Communal non-profit enterprise Regional Center of Oncology /ID# 226976 Kharkiv Ukraine 61070
    253 National Cancer Institute /ID# 230221 Kyiv Ukraine 03022
    254 University Hospital of Derby and Burton NHS Foundation Trust /ID# 234093 Derby Derbyshire United Kingdom DE22 3NE
    255 Barts Health NHS Trust /ID# 230028 London London, City Of United Kingdom E1 2ES
    256 Oxford University Hospitals NHS Foundation Trust /ID# 230035 Oxford Oxfordshire United Kingdom OX3 9DU
    257 NHS Greater Glasgow and Clyde /ID# 230027 Glasgow Scotland United Kingdom G12 0XH
    258 University Hospitals of North Midlands NHS Trust /ID# 230042 Stoke-on-Trent Staffordshire United Kingdom ST4 6QG
    259 University Hospitals Birmingham NHS Foundation Trust /ID# 230043 Birmingham United Kingdom B15 2TH
    260 East Kent Hospitals University NHS Foundation Trust /ID# 230152 Canterbury United Kingdom CT1 3NG
    261 East Suffolk and North Essex NHS Foundation Trust /ID# 230040 Colchester United Kingdom CO4 5JL
    262 Leeds Teaching Hospitals NHS Trust /ID# 230471 Leeds United Kingdom LS9 7TF
    263 The Clatterbridge Cancer Centre NHS Foundation Trust /ID# 230036 Liverpool United Kingdom L7 8YA
    264 The Christie Hospital /ID# 230124 Manchester United Kingdom M20 4BX
    265 The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 230123 Newcastle Upon Tyne United Kingdom NE7 7DN
    266 University Hospital Plymouth NHS Trust /ID# 230038 Plymouth United Kingdom PL6 5FP
    267 Portsmouth Hospitals University NHS Trust /ID# 230044 Portsmouth United Kingdom PO6 3LY
    268 South Tyneside and Sunderland NHS Foundation Trust /ID# 230039 South Shields United Kingdom NE34 0PL

    Sponsors and Collaborators

    • AbbVie
    • Genmab

    Investigators

    • Study Director: ABBVIE INC., AbbVie

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    AbbVie
    ClinicalTrials.gov Identifier:
    NCT05409066
    Other Study ID Numbers:
    • M20-638
    • 2021-000169-34
    First Posted:
    Jun 8, 2022
    Last Update Posted:
    Jun 8, 2022
    Last Verified:
    Jun 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by AbbVie
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 8, 2022